Prostacyclin formation by the pregnant human myometrium

Area of Science:

• Reproductive biology
• Biochemistry
• Obstetrics

Background:

• The human myometrium, the muscular layer of the uterus, plays a critical role in pregnancy and parturition.
• Prostacyclin is a potent vasodilator and inhibitor of platelet aggregation with potential roles in physiological processes.

Purpose of the Study:

• To investigate the in vitro release of biologically active substances from the human myometrium during pregnancy.
• To characterize the properties of a myometrium-derived anti-aggregatory material and compare it to prostacyclin.
• To assess changes in the production of this material throughout gestation and its potential link to parturition.

Main Methods:

• Collection of human myometrium samples at various gestational ages (15-42 weeks).
• In vitro incubation of myometrial tissue to collect released substances.
• Assay of anti-aggregatory activity of the collected material.
• Comparison of material's stability and sensitivity to indomethacin with authentic prostacyclin.

Main Results:

• Human myometrium released an in vitro material exhibiting significant anti-aggregatory activity.
• This material shared properties with prostacyclin, including stability at alkaline pH and indomethacin-sensitive generation.
• Myometrial production of the prostacyclin-like material remained stable until week 38 but increased fourfold by week 40 of pregnancy.

Conclusions:

• The human myometrium synthesizes and releases a prostacyclin-like substance with anti-aggregatory properties.
• The observed late-gestational increase in synthesis suggests this material may play a role in initiating or facilitating parturition.